$OMCL News

Last published 1w ago

1w agoOMCLOMNICELL, INC. - EX-99.1Earnings ReleasesForm 8-K - Current report - Item 2.02 Item 9.01
1w agoOMCLOmnicell Announces Third Quarter 2026 Financial ResultsBusiness WireOmnicell delivers solid third quarter 2026 financial results Updates full year 2026 guidance Omnicell, Inc. (NASDAQ:OMCL) ("Omnicell," "we," "our," or the "Company"), a healthcare
1mo agoOMCLOmnicell to Release Third Quarter 2026 Financial Results on October 29, 2026Business WireOmnicell, Inc. (NASDAQ:OMCL), a leading healthcare technology provider focused on empowering autonomous medication management, will release its financial results for the third quarter 2026, before market open on
2mo agoOMCLTraceLink and Omnicell Integrate DSCSA Compliance Solution into Hospital Pharmacy OperationsPR NewswireTraceLink, the world's largest Agentic Business Network for the life sciences and healthcare supply chain, today announced an integration between its ...
2mo agoOMCLOmnicell to Present at the Wells Fargo 21st Annual Healthcare ConferenceBusiness WireOmnicell, Inc. (NASDAQ:OMCL), a leading healthcare technology provider focused on empowering autonomous medication management, announced that it will present at the Wells Fargo 21st Annual Healthcare Conference on
3mo agoOMCLEnlivenHealth Highlights VaxReach Ahead of ThoughtSpot 2026 — Designed to Help Pharmacies Strengthen Communities Through VaccinationBusiness WireNew solution may help pharmacies grow monthly vaccinations by up to 66%1 EnlivenHealth, Inc., a subsidiary of Omnicell, Inc. ("EnlivenHealth") and a leading innovator in pharmacy technology and patient
3mo agoOMCLOmnicell Announces Second Quarter 2026 Financial ResultsBusiness WireOmnicell delivers solid second quarter 2026 financial results Updates full year 2026 guidance Omnicell, Inc. (NASDAQ:OMCL) ("Omnicell," "we," "our," or the "Company"), a leading
4mo agoOMCLOmnicell to Release Second Quarter 2026 Financial Results on July 30, 2026Business WireOmnicell, Inc. (NASDAQ:OMCL), a leading healthcare technology provider focused on empowering autonomous medication management, will release its financial results for the second quarter 2026, before market open on
4mo agoOMCLRobotics Standards Update: AMR Interoperability, Humanoid Safety & What's Next | Automate Rewind - OMNICELL INCEarnings Call TranscriptsHi, welcome back to Automate Live. Again, I'm Jana Martin, part of the Association for Advancing Automation, and I am joined by three of my colleagues, Carol Franklin, Maren Rausch, and Aaron Prather. We'll talk about wh
4mo agoOMCLNnamdi Njoku Appointed President of OmnicellBusiness WireNjoku continues to lead global operations and advance Omnicell's innovation and AI platform strategy; Randall Lipps continues to serve as Chief Executive Officer and Chairman of the Board Omnicell, Inc.
5mo agoOMCLOmnicell Selects Dan Mandoli to Lead Specialty Pharmacy Services BusinessBusiness WireSeasoned healthcare executive with deep expertise in specialty pharmacy operations named Senior Vice President and General Manager Omnicell, Inc. (NASDAQ:OMCL) ("Omnicell" or the "Company"), a leading healthcare
5mo agoOMCLOmnicell to Present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026Business WireOmnicell, Inc. (NASDAQ:OMCL), a leading healthcare technology provider focused on empowering autonomous medication management, announced that it will present at the Goldman Sachs 47th Annual Global Healthcare Conference
6mo agoOMCL2026 GLOBAL HEALTHCARE CONFERENCEOMNICELL INCEarnings Call TranscriptsWe have CFO Baird Radford, and before I get started with questions, he has a couple of prepared remarks. Good morning, everybody. During the course of this discussion, I'll certainly make some forward-looking statements,
6mo agoOMCLOmnicell to Present at the BofA Securities 2026 Healthcare ConferenceBusiness WireOmnicell, Inc. (NASDAQ:OMCL), a leading healthcare technology provider focused on empowering autonomous medication management, announced that it will present at the BofA Securities 2026 Healthcare Conference on Tuesday,
6mo agoOMCLOmnicell Welcomes Hospital Pharmacy Leader Rick Couldry as Senior Vice President, Chief Pharmacy and Clinical OfficerBusiness WireNewly established role strengthens understanding of healthcare clinician needs to help shape the Company's innovation priorities and portfolio decisions Omnicell, Inc. (NASDAQ:OMCL) ("Omnicell" or the "Company"), a
6mo agoOMCLOmnicell First Quarter 2026 Financial Results CallOMNICELL INCEarnings Call TranscriptsThank you for standing by. My name is Tina, and I will be your conference operator today. At this time, I would like to welcome everyone to the OmniCell First Quarter 2026 Financial Results Call. All lines have been plac
6mo agoOMCLOmnicell Announces First Quarter 2026 Financial ResultsBusiness WireOmnicell delivers strong first quarter 2026 financial results Raises full year 2026 non-GAAP EBITDA and non-GAAP EPS guidance Customer engagement underway for Omnicell Titan XT and OmniSphere Omnicell, Inc.
7mo agoOMCLOmnicell to Release First Quarter 2026 Financial Results on April 28, 2026Business WireOmnicell, Inc. (NASDAQ:OMCL), a leading healthcare technology provider focused on empowering autonomous medication management, will release its financial results for the first quarter 2026, before market open on
7mo agoAMZN HON NVDA OMCL+1AI-Driven Compliance Gamechanger in Pharma Manufacturing and Regulatory StandardsGlobeNewswireAUSTIN, Texas, April 07, 2026 (GLOBE NEWSWIRE) -- AINewsWire Editorial Coverage: As regulatory expectations intensify and manufacturing complexity grows, pharmaceutical companies are moving beyond traditional quality
9mo agoOMCLOmnicell Fiscal Year and Fourth Quarter 2025 ResultsOMNICELL INCEarnings Call TranscriptsHello and welcome to the OmniCell Fiscal Year and Fourth Quarter 2025 results. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question and answer session.
9mo agoOMCLOmnicell Announces Fiscal Year and Fourth Quarter 2025 Financial ResultsBusiness WireOmnicell delivers solid fourth quarter 2025 financial results Announces major step toward autonomous medication management with the launch of its next generation dispensing system, Titan XT, at the American Society of
11mo agoOMCLAnnouncing Omnicell Titan XT, the Next Generation, Automated Dispensing System Designed to Empower Autonomous Medication ManagementBusiness WirePowered by OmniSphere, Titan XT is built to support evolving healthcare needs while delivering greater pharmacy control and nursing confidence for a growing enterprise Omnicell, Inc. (NASDAQ:OMCL), a leading healthcare
11mo agoOMCLOmnicell to Host Innovation Update and Q&A Session at Upcoming ASHP Midyear Industry Trade ShowBusiness WireOmnicell, Inc. (NASDAQ:OMCL), a leader in transforming the pharmacy and nursing care delivery model, will host an Innovation Update and Investor Q&A Session during the upcoming ASHP Midyear Clinical Meeting &
11mo agoOMCLOmnicell to Present at the Piper Sandler 37th Annual Healthcare ConferenceBusiness WireOmnicell, Inc. (NASDAQ:OMCL), a leader in transforming the pharmacy and nursing care delivery model, announced that it will present at the Piper Sandler 37th Annual Healthcare Conference on Tuesday, December 2, 2025, at
12mo agoOMCLOmnicell Achieves URAC Certification, Strengthening Compliance and Scalability for Health System-Owned Specialty PharmaciesBusiness WireNational certification demonstrates enterprise-grade oversight of specialty pharmacy enablement programs In a move that reinforces its leadership in enabling health system-owned specialty pharmacy growth, Omnicell,
1y agoOMCLOmnicell Announces Third Quarter 2025 Financial ResultsBusiness WireOmnicell delivers strong third quarter financial results Results exceed previously issued third quarter 2025 guidance on all metrics Raises full year 2025 total revenues, non-GAAP EBITDA and non-GAAP EPS
1y agoOMCLOmnicell to Release Third Quarter 2025 Financial Results on October 30, 2025Business WireOmnicell, Inc. (NASDAQ:OMCL), a leader in transforming the pharmacy and nursing care delivery model, will release its financial results for the third quarter 2025, before market open on Thursday, October 30, 2025. The
1y agoEVOK OMCLEvoke Pharma and EVERSANA Expand GIMOTI® Access to Gastro Health and Other Large GI Practices through Omnicell RelationshipGlobeNewswireSeparately Secures Access to OneGI Through Brentwood Pharmacy Agreement Gimoti Specialty Pharmacy Network to Almost Double with Additional Relationships SOLANA BEACH, Calif. and CHICAGO, Aug. 26, 2025 (GLOBE
1y agoOMCLOmnicell Appoints Baird Radford as Executive Vice President and Chief Financial OfficerBusiness WireSeasoned leader brings more than 30 years of experience driving growth for healthcare and technology companies Omnicell, Inc. (NASDAQ:OMCL) ("Omnicell" or the "Company"), a leader in transforming the pharmacy and
1y agoOMCLOmnicell, Inc. (OMCL) Q2 2025 Earnings Conference Call TranscriptEarnings Call Transcripts
1y agoOMCLOmnicell Announces Second Quarter 2025 ResultsBusiness WireOmnicell delivers strong second quarter financial results Results exceed previously issued second quarter 2025 guidance for revenues, non-GAAP EBITDA and non-GAAP EPS Raises full year 2025 total revenues, non-GAAP
1y agoOMCLOmnicell to Release Second Quarter 2025 Financial Results on July 31, 2025Business WireOmnicell, Inc. (NASDAQ:OMCL), a leader in transforming the pharmacy and nursing care delivery model, will release its financial results for the second quarter 2025, before market open on Thursday, July 31, 2025. The
1y agoOMCLOmnicell Expects Improved Profitability, Updates Second Quarter and Full Year 2025 Profit Outlook and Announces a New Stock Repurchase ProgramBusiness WireOmnicell, Inc. (NASDAQ:OMCL) ("Omnicell," "we," "our," "us," "management," or the "Company"), a leader in transforming the pharmacy and nursing care delivery model, today announced updates to its second quarter and full
1y agoOMCLOmnicell Announces New Products for Perioperative and Clinic SettingsBusiness WireRFID-Enabled Dispensing and Intelligent Inventory Management Software Aim to Unlock Greater Inventory Accuracy and Streamline Medication Management in Operating Rooms and Outpatient Clinics Omnicell, Inc. (NASDAQ:OMCL)
1y agoOMCLOmnicell Opens New Innovation Lab in Austin, TexasBusiness WireCompany Establishes New Hub Dedicated to Addressing Challenges Across the Medication Journey Omnicell, Inc. (NASDAQ:OMCL), ("Omnicell" or the "Company"), a leader in transforming the pharmacy and nursing care delivery
1y agoOMCLOmnicell Announces First Quarter 2025 ResultsBusiness WireOmnicell delivers solid first quarter financial results Results exceed previously issued first quarter 2025 guidance for total revenues and non-GAAP EPS Updates full year 2025 non-GAAP EBITDA and non-GAAP EPS
1y agoOMCLOmnicell to Release First Quarter 2025 Financial Results on May 6, 2025Business WireOmnicell, Inc. (NASDAQ:OMCL), a leader in transforming the pharmacy and nursing care delivery model, will release its financial results for the first quarter 2025, before market open on Tuesday, May 6, 2025. The Company
1y agoOMCLOmnicell Welcomes Perry A. Genova, PhD, as Chief Technology OfficerBusiness WireMedical device, pharmaceutical, and life sciences expert tapped to lead Company's technology strategy and global engineering organization Omnicell, Inc. (NASDAQ:OMCL) ("Omnicell" or the "Company"), a leader in
1y agoOMCLOmnicell Announces Chief Financial Officer TransitionBusiness WireCompany Reiterates First Quarter and Full Year 2025 Guidance Omnicell, Inc. (NASDAQ:OMCL) ("Omnicell," "we," "our," "us," "management," or the "Company"), a leader in transforming the pharmacy and nursing care delivery
1y agoOMCLOmnicell Announces Fiscal Year and Fourth Quarter 2024 ResultsBusiness WireOmnicell delivers strong fourth quarter financial results Results exceed previously issued full year guidance for bookings, total revenues, and non-GAAP EBITDA Omnicell, Inc. (NASDAQ:OMCL) ("Omnicell," "we," "our,"
1y agoOMCLOmnicell to Release Fourth Quarter and Full Year 2024 Financial Results on February 6, 2025Business WireOmnicell, Inc. (NASDAQ:OMCL), a leader in transforming the pharmacy and nursing care delivery model, will release its financial results for the fourth quarter and full year 2024, before market open on Thursday, February
1y agoOMCLOmnicell to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceBusiness WireOmnicell, Inc. (NASDAQ:OMCL), a leader in transforming the pharmacy care delivery model, announced that it will present at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025 at 1:30 p.m.
1y agoOMCLOmnicell Announces OmniSphereBusiness WireNext-generation, cloud native, software workflow engine and data platform intended to seamlessly integrate enterprise robotics and smart devices across the continuum of care Company Showcases New and Enhanced
1y agoOMCLOmnicell to Present at the Piper Sandler 36th Annual Healthcare ConferenceBusiness WireOmnicell, Inc. (NASDAQ:OMCL), a leader in transforming the pharmacy care delivery model, announced that it will present at the Piper Sandler 36th Annual Healthcare Conference on Tuesday, December 3, 2024 at 2:00 p.m.
1y agoOMCLOmnicell Announces Pricing of $150 Million Convertible Senior Notes OfferingBusiness WireOmnicell, Inc. (NASDAQ:OMCL) ("Omnicell") today announced the pricing of $150.0 million aggregate principal amount of 1.00% Convertible Senior Notes due 2029 (the "notes") in a private placement (the "offering") to
1y agoOMCLOmnicell Announces Proposed Private Placement of $150 Million of Convertible Senior NotesBusiness WireOmnicell, Inc. (NASDAQ:OMCL) ("Omnicell") today announced that it intends to offer, subject to market conditions and other factors, $150.0 million aggregate principal amount of Convertible Senior Notes due 2029 (the
2y agoOMCLOmnicell, Inc. (OMCL) Q3 2024 Earnings Call TranscriptEarnings Call Transcripts
2y agoOMCLOmnicell Announces Third Quarter 2024 ResultsBusiness WireOmnicell delivers solid third quarter financial results Total revenues of $282 million GAAP net income per diluted share of $0.19 Non-GAAP net income per diluted share of $0.56 Raises 2024 non-GAAP EBITDA and
2y agoOMCLOmnicell to Release Third Quarter 2024 Financial Results on October 30, 2024Business WireOmnicell, Inc. (NASDAQ:OMCL), a leader in transforming the pharmacy care delivery model, will release its financial results for the third quarter 2024, before market open on Wednesday, October 30, 2024. The Company will
2y agoOMCLOmnicell Appoints Nnamdi Njoku as Executive Vice President and Chief Operating OfficerBusiness WireThe Company taps business and operations executive with expertise that spans healthcare and med tech to help scale pharmacy automation and drive multi-year innovation and excellence Omnicell, Inc. (NASDAQ:OMCL)